Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: Saw Palmetto Extract in Benign Prostatic Hyperplasia [Phase 3]
A Phase 3 clinical trial evaluating Saw Palmetto Extract for Benign Prostatic Hyperplasia has completed, sponsored by the National Institute…
-
CLINICAL_TRIALS research · 2010-01-06Clinical Trial Update: Study of the Effects of Pomegranate Tablets on Enlarged Prostates [Phase 1]
Phase 1 clinical trial evaluating the effects of pomegranate tablets on Benign Prostatic Hyperplasia, sponsored by the University of Califor…
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo [Phase 3]
A Phase 3 clinical trial evaluating a new drug for benign prostatic hyperplasia versus placebo has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo [Phase 3]
A Phase 3 trial evaluating a new drug for benign prostatic hyperplasia versus placebo has completed, with results posted.
-
CLINICAL_TRIALS research · 2009-11-26Clinical Trial Update: Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions [Phase 4]
A Phase 4 clinical study is evaluating whether a saw palmetto preparation influences sexual dysfunction in men with benign prostatic hyperpl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia [Phase 2]
This entry notes the completion of a Phase 2 dose-ranging study of alfuzosin for lower urinary tract symptoms related to benign prostatic hy…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia [Phase 3]
Phase 3 trial comparing Alfuzosin to placebo and Tamsulosin in Japanese men with benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH [Phase 3]
Phase 3 clinical trial update reporting long-term safety data for Alfuzosin (SL77.0499-10) in men with Benign Prostatic Hyperplasia.
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration [NA]
This clinical trial update reports on transurethral needle ablation (TUNA) for benign prostatic hyperplasia. The study status is completed a…
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin [Phase 4]
This update reports the completion of the Phase 4 SAMBA trial evaluating the sexual function and management of symptoms in men with benign p…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin [Phase 4]
Phase 4 clinical trial update evaluating the impact of alfuzosin on sexuality and management of benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 2, Phase 3]
Phase 2 and Phase 3 trials evaluated once-daily tadalafil for 12 weeks in men with signs and symptoms of benign prostatic hyperplasia, with …
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men [Phase 2]
Phase 2 pilot study assessing the safety and efficacy of tadalafil for benign prostatic hyperplasia in Asian men; results were posted in 200…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 2]
Results from a Phase 2 trial evaluating once-daily tadalafil for 12 weeks in men with signs and symptoms of benign prostatic hyperplasia, as…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction [Phase 4]
Phase 4 clinical trial evaluating dutasteride's effect on bladder wall hypertrophy in men with benign prostatic hyperplasia and obstruction.…
-
CLINICAL_TRIALS trial_result · 2009-05-25Clinical Trial Update: Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia [NA]
Clinical trial update on the use of 80 W KTP laser vaporization prostatectomy and its effect on obstruction severity in men with benign pros…
-
FDA label_change · 2009-05-20FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) submitted by Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia [Phase 3]
A Phase 3 clinical trial evaluating lonidamine for symptomatic benign prostatic hyperplasia was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia [Phase 2]
Phase 2 study evaluating lonidamine for symptomatic benign prostatic hyperplasia was terminated. The update does not include efficacy or saf…
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects [Phase 3]
Phase 3 trial update for Dutasteride (GI198745) in benign prostatic hyperplasia. Study completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia [NA]
Clinical trial evaluating the effects of isoflavone in men with watchful waiting Benign Prostatic Hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH [Phase 3]
Phase 3 randomized trial comparing alfuzosin 10 mg once daily to placebo for acute urinary retention due to benign prostatic hyperplasia; th…
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH [Phase 3]
Phase 3 trial evaluating the efficacy and safety of silodosin for signs and symptoms of benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-25Clinical Trial Update: A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 [Phase 1]
This Phase 1 trial is a randomized, double-blind, placebo-controlled two-way crossover study to assess the safety and tolerability of a sing…
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia
A pharmacovigilance clinical trial evaluating the safety of AVODART (dutasteride) in men with benign prostatic hyperplasia has completed.